Evogene Ltd. (EVGN) Stock Forecast Oct. 13, 2026
Analysis updated on Oct. 13, 2026 (UTC) · Total · absolute moveSwitch to Alpha · Nasdaq
Evogene Ltd. (EVGN) stock forecast summary
Our AI ranks Evogene Ltd. outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
Evogene Ltd. is a small-cap company with a market capitalization of $3M. It ranks number 10 by market capitalization among the 10 Agricultural Chemicals issuers in our coverage with a current forecast.
A per-ticker accuracy statistic for EVGN is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected absolute price move over the horizon, market included. This is the number a price target is built from. Ratings: strong buy ≥ +4.5%, buy ≥ +3.4%, sell < +2.1%, strong sell < +0.9% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-13 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, EVGN included.
Follow EVGN freeEVGN price chart and AI forecast
How EVGN ranks among 5379 stocks
90D Total forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Evogene Ltd. (EVGN) fundamentals
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Agricultural Chemicals peers listed below that report each metric.
Financial statement data is not available for this company: its filings are not in a form the pipeline converts, so only market data is shown.
Valuation & Market
| Metric | EVGN | Rank |
|---|---|---|
| Market Cap | $3M | 10/10 |
Dividend & Shareholder Information
| Metric | EVGN | Rank |
|---|---|---|
| Shares Outstanding | 9M | – |
EVGN quarterly financials and insider trading
Evogene Ltd. (EVGN) industry peers
Companies classified under the same SEC industry code as Evogene Ltd. (Agricultural Chemicals): 12 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up free| Company | 90-Day AI Forecast (Total) | Market Cap |
|---|---|---|
| EVGN Evogene Ltd. | ▲ | $3M |
| NTR Nutrien Ltd. | ▼ | $33.89B |
| CF Cf Industries Holdings, Inc. | ▼ | $17.74B |
| ICL Icl Group Ltd. | ▼ | $6.43B |
| MOS Mosaic Co | ▼ | $6.10B |
| SMG Scotts Miracle-Gro Co | ▶ | $2.92B |
| UAN Cvr Partners, Lp | ▼ | $1.33B |
| AVD American Vanguard Corp | ▲ | $42M |
| BNET Bion Environmental Technologies Inc | ▲ | $9M |
| SNES Senestech, Inc. | ▲ | $4M |
| BIOX Bioceres Crop Solutions Corp. | ▲ | N/A |
| CBUS Cibus, Inc. | ▲ | N/A |
Where EVGN sits on the market map
Evogene Ltd. (EVGN) stock news
Loading...
Evogene Ltd. (EVGN) stock forecast FAQ
What is the Evogene Ltd. (EVGN) stock forecast?
Our AI ranks Evogene Ltd. outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
How accurate are Evogene Ltd. stock predictions?
A per-ticker accuracy statistic for EVGN is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are Evogene Ltd. forecasts updated?
Evogene Ltd. forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 13, 2026.
Which companies are Evogene Ltd.'s industry peers?
12 issuers in our coverage, EVGN included, share the SEC industry code Agricultural Chemicals. The largest are: Nutrien Ltd. (NTR), Cf Industries Holdings, Inc. (CF), Icl Group Ltd. (ICL), Mosaic Co (MOS), Scotts Miracle-Gro Co (SMG), Cvr Partners, Lp (UAN).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.